$839.87
2.44% day before yesterday
NYSE, Oct 03, 10:11 pm CET
ISIN
US5324571083
Symbol
LLY

Eli Lilly and Company Stock price

$839.87
+102.04 13.83% 1M
+50.78 6.44% 6M
+67.87 8.79% YTD
-45.68 5.16% 1Y
+518.32 161.19% 3Y
+693.24 472.78% 5Y
+753.30 870.16% 10Y
+786.94 1,486.76% 20Y
NYSE, Closing price Fri, Oct 03 2025
+20.02 2.44%

Key metrics

Basic
Market capitalization
$794.9b
Enterprise Value
$831.3b
Net debt
$36.4b
Cash
$3.5b
Shares outstanding
946.8m
Valuation (TTM | estimate)
P/E
54.8 | 36.6
P/S
14.9 | 12.8
EV/Sales
15.6 | 13.3
EV/FCF
negative
P/B
43.5
Dividends
DPS
$5.20
Yield 1Y | 5Y
0.6% | 1.0%
Growth 1Y | 5Y
15.0% | 15.1%
Payout 1Y | 3Y
44.4% | 55.9%
Increased
10 Years
Financials (TTM | estimate)
Revenue
$53.3b | $62.3b
EBITDA
$24.3b | $27.6b
EBIT
$22.4b | $25.8b
Net Income
$13.8b | $21.7b
Free Cash Flow
$-50.2m
Growth (TTM | estimate)
Revenue
36.8% | 38.3%
EBITDA
61.8% | 46.7%
EBIT
67.1% | 51.3%
Net Income
88.0% | 105.2%
Free Cash Flow
98.6%
Margin (TTM | estimate)
Gross
82.6%
EBITDA
45.7% | 44.3%
EBIT
42.1%
Net
25.9% | 34.9%
Free Cash Flow
-0.1%
Financial Health
Equity Ratio
18.0%
Return on Equity
74.6%
ROCE
36.3%
ROIC
23.0%
Debt/Equity
2.2
More
EPS
$15.3
FCF per Share
$-0.1
Short interest
0.9%
Employees
47k
Rev per Employee
$960.0k
Show more

Is Eli Lilly and Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Eli Lilly and Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

35 Analysts have issued a Eli Lilly and Company forecast:

26x Buy
74%
9x Hold
26%

Analyst Opinions

35 Analysts have issued a Eli Lilly and Company forecast:

Buy
74%
Hold
26%

Financial data from Eli Lilly and Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
53,258 53,258
37% 37%
100%
- Direct Costs 9,247 9,247
23% 23%
17%
44,012 44,012
40% 40%
83%
- Selling and Administrative Expenses 9,746 9,746
25% 25%
18%
- Research and Development Expense 11,826 11,826
16% 16%
22%
24,332 24,332
62% 62%
46%
- Depreciation and Amortization 1,893 1,893
17% 17%
4%
EBIT (Operating Income) EBIT 22,439 22,439
67% 67%
42%
Net Profit 13,800 13,800
88% 88%
26%

In millions USD.

Don't miss a Thing! We will send you all news about Eli Lilly and Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eli Lilly and Company Stock News

Positive
Seeking Alpha
2 days ago
Drug stocks are poised to outperform in 2025, driven by conservative valuations and a research renaissance in key therapeutic areas. US healthcare spending growth and transformative GLP-1 therapies, especially from LLY and NVO, provide powerful tailwinds for the sector. Advances in oncology, hematology, and new cardiology drugs like Lp(a) inhibitors create multi-billion dollar opportunities for...
Neutral
The Motley Fool
2 days ago
Shares in Eli Lilly (LLY 2.73%) had risen 13.2% in the week to Friday morning. The move comes at a time when peer Pfizer announced a deal with the Trump administration that gave that pharmaceutical company three years of grace from tariffs imposed on drugs it manufactures abroad and imports to the U.S..
Positive
Seeking Alpha
2 days ago
I track a universe of 50 high-quality dividend growth stocks to identify opportune investments based on valuation and future return potential. As of October 2, 2025, 22 stocks offer attractive future return estimates of at least 10%, with 15 appearing potentially undervalued by my Free Cash Flow model. Top-ranked stocks include MKTX, RMD, MPWR, RACE, and MSCI, each offering strong projected ret...
More Eli Lilly and Company News

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Head office United States
CEO David Ricks
Employees 47,000
Founded 1876
Website www.lilly.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today